Glycobiology of platelet-endothelial cell interactions

Glycobiology

Volumn 24, Issue 12, 2014, Pages 1252-1259

  Etulain, Julia ^a   Schattner, Mirta ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Angiogenesis; Endothelial cells; Glycobiology; Inflammation; Platelets

Indexed keywords

ANGIOSTATIN; C TYPE LECTIN LIKE RECEPTOR 2; CARBOHYDRATE BINDING PROTEIN; CD31 ANTIGEN; CHONDROITIN; DERMATAN SULFATE; ENDOSTATIN; GALECTIN; GALECTIN 1; GALECTIN 3; GALECTIN 8; GLYCAN; GLYCOPROTEIN IB ALPHA; GLYCOSAMINOGLYCAN BINDING PROTEIN; GLYCOSPHINGOLIPID; HEPARAN SULFATE; HEPARIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LECTIN RECEPTOR; LIPID; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG; VASCULOTROPIN; POLYSACCHARIDE;

ANGIOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; ENDOTHELIUM CELL; GLYCOBIOLOGY; GLYCOSYLATION; HEMOPHILIA; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; REVIEW; SIALYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOSIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; CYTOLOGY; METABOLISM;

BLOOD PLATELETS; CELL COMMUNICATION; ENDOTHELIAL CELLS; GLYCOMICS; HUMANS; POLYSACCHARIDES;

EID: 84925690223     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu056     Document Type: Review

References (101)

1. Aidoudi S, Bikfalvi A. 2010. Interaction of PF4 (CXCL4) with the vasculature: A role in atherosclerosis and angiogenesis. Thromb Haemost. 104:941-948.
2. Al-Ansari S, Zeebregts CJ, Slart RH, Peppelenbosch M, Tio RA 2009. Galectins in atherosclerotic disease. Trends Cardiovasc Med. 19:164-169.
3. Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD 2000. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood. 96:3322-3328.
4. Angata T, Brinkman-Van der Linden E. 2002. I-type lectins. Biochim Biophys Acta. 1572:294-316.
5. Baltus T, von Hundelshausen P, Mause SF, Buhre W, Rossaint R, Weber C. 2005. Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J Leukoc Biol. 78:435-441.
6. Baum LG, Seilhamer JJ, Pang M, Levine WB, Beynon D, Berliner JA 1995. Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconj J. 12:63-68.
7. Beacham DA, Lian J, Wu G, Konkle BA, Ludlow LB, Shapiro SS 1999. Arterial shear stress stimulates surface expression of the endothelial glycoprotein Ib complex. J Cell Biochem. 73:508-521.
8. Bendas G, Borsig L. 2012. Cancer cell adhesion and metastasis: Selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol. 2012:676731.
9. Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY, Xu B, Lu MM, Zhou D, et al 2010. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 116:661-670.
10. Bombeli T, Schwartz BR, Harlan JM 1998. Adhesion of activated platelets to endothelial cells: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med. 187:329-339.
11. Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, Guglielmi J, Clezardin P, Peyruchaud O. 2004. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest. 114:1714-1725.
12. Buckley CD, Doyonnas R, Newton JP, Blystone SD, Brown EJ, Watt SM, Simmons DL 1996. Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci. 109(Pt 2):437-445.
13. Cao TM, Takatani T, King MR 2013. Effect of extracellular pH on selectin adhesion: Theory and experiment. Biophys J. 104:292-299.
14. Carramolino L, Fuentes J, Garcia-Andres C, Azcoitia V, Riethmacher D, Torres M. 2010. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res. 106:1197-1201.
15. Casu B, Naggi A, Torri G. 2010. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biol. 29:442-452.
16. Cattaneo V, Tribulatti MV, Carabelli J, Carestia A, Schattner M, Campetella O. 2014. Galectin-8 elicits pro-inflammatory activities in the endothelium. Glycobiology. 24:966-973.
17. Celik S, Langer H, Stellos K, May AE, Shankar V, Kurz K, Katus HA, Gawaz MP, Dengler TJ 2007. Platelet-associated LIGHT (TNFSF14) mediates adhesion of platelets to human vascular endothelium. Thromb Haemost. 98:798-805.
18. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, et al 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91:3527-3561.
19. Croci DO, Cerliani JP, Dalotto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, Garcia-Vallejo JJ, Ouyang J, et al 2014. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell. 156:744-758.
20. Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI, et al 2012. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. J Exp Med. 209: 1985-2000.
21. Cha JK, Jeong MH, Bae HR, Han JY, Jeong SJ, Jin HJ, Lim YJ, Kim SH, Kim JW 2000. Activated platelets induce secretion of interleukin-1beta, monocyte chemotactic protein-1, and macrophage inflammatory protein-1alpha and surface expression of intercellular adhesion molecule-1 on cultured endothelial cells. J Korean Med Sci. 15:273-278.
22. Chadderton NS, Stringer SE 2003. Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate. Int J Biochem Cell Biol. 35:1052-1055.
23. Chen J, Lopez JA 2005. Interactions of platelets with subendothelium and endothelium. Microcirculation. 12:235-246.
24. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM 1989. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell. 58:945-953.
25. da Costa Martins P, Garcia-Vallejo JJ, van Thienen JV, Fernandez-Borja M, van Gils JM, Beckers C, Horrevoets AJ, Hordijk PL, Zwaginga JJ. 2007. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol. 27:1023-1029.
26. Delgado VM, Nugnes LG, Colombo LL, Troncoso MF, Fernandez MM, Malchiodi EL, Frahm I, Croci DO, Compagno D, Rabinovich GA, et al 2011. Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8. FASEB J. 25:242-254.
27. Etulain J, Negrotto S, Carestia A, Pozner RG, Romaniuk MA, D'Atri LP, Klement GL, Schattner M. 2012. Acidosis downregulates platelet haemostatic functions and promotes neutrophil proinflammatory responses mediated by platelets. Thromb Haemost. 107:99-110.
28. Etulain J, Negrotto S, Schattner M. 2013. Role of platelets in angiogenesis in health and disease. Curr Angiogenesis. 2:1-10.
29. Etulain J, Negrotto S, Tribulatti MV, Croci DO, Carabelli J, Campetella O, Rabinovich GA, Schattner M. 2014. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors. PLoS ONE. 9: e96402.
30. Etulain J, Schattner M. 2012. Current viewpoints on platelet contribution to inflammation. World JHematol. 1:14-21.
31. Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, McGregor JL, de Gaetano G, Cerletti C. 1996. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: Evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. Blood. 88:4183-4194.
32. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, Croce K, Furie BC, Furie B. 2003. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. JExp Med. 197:1585-1598.
33. Finney BA, Schweighoffer E, Navarro-Nunez L, Benezech C, Barone F, Hughes CE, Langan SA, Lowe KL, Pollitt AY, Mourao-Sa D, et al 2012. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood. 119:1747-1756.
34. Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD 2000. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med. 191:1413-1422.
35. Gawaz M, Neumann FJ, Dickfeld T, Koch W, Laugwitz KL, Adelsberger H, Langenbrink K, Page S, Neumeier D, Schomig A, et al 1998. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation. 98:1164-1171.
36. Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H, Rockwell P, Maione TE, Levi BZ, Neufeld G. 1995. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem. 270:15059-15065.
37. Gidlof O, van der Brug M, Ohman J, Gilje P, Olde B, Wahlestedt C, Erlinge D. 2013. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood. 121:3908-3917, S3901-3926.
38. Hess PR, Rawnsley DR, Jakus Z, Yang Y, Sweet DT, Fu J, Herzog B, Lu M, Nieswandt B, Oliver G, et al 2014. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J Clin Invest. 124:273-284.
39. Heusschen R, Schulkens IA, van Beijnum J, Griffioen AW, Thijssen VL 2014. Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis. Biochim Biophys Acta. 1842:284-292.
40. Hrachovinova I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, Xia L, Kazazian HH, Jr, Schaub RG, McEver RP, et al. 2003. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med. 9:1020-1025.
41. Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, Nishi N, Fujimoto K, Tanji K, Shibata T, et al. 2002. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol. 72:486-491.
42. Johnston GI, Cook RG, McEver RP 1989. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation. Cell. 56:1033-1044.
43. Jurasz P, Santos-Martinez MJ, Radomska A, Radomski MW 2006. Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis. J Thromb Haemost. 4:1095-1106.
44. Kaltner H, Gabius HJ 2001. Animal lectins: From initial description to elaborated structural and functional classification. Adv Exp Med Biol. 491:79-94.
45. Karshovska E, Weber C, von Hundelshausen P. 2013. Platelet chemokines in health and disease. Thromb Haemost. 110:894-902.
46. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, et al. 2001. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell. 7:811-822.
47. Katz JN, Kolappa KP, Becker RC 2011. Beyond thrombosis: The versatile platelet in critical illness. Chest. 139:658-668.
48. Kerr SC, Fieger CB, Snapp KR, Rosen SD 2008. Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins. J Immunol. 181:1480-1490.
49. Kim H, Koh GY 2010. Platelets take the lead in lymphatic separation. Circ Res. 106:1184-1186.
50. Koenig A, Jain R, Vig R, Norgard-Sumnicht KE, Matta KL, Varki A. 1997. Selectin inhibition: Synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. Glycobiology. 7:79-93.
51. Kozlowski EO, Pavao MS, Borsig L. 2011. Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. J Thromb Haemost. 9:1807-1815.
52. Lam FW, Burns AR, Smith CW, Rumbaut RE 2011. Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. Am J Physiol Heart Circ Physiol. 300:H468-H475.
53. Lawson C, Wolf S. 2009. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 61:22-32.
54. Lee MJ, Gravelat FN, Cerone RP, Baptista SD, Campoli PV, Choe SI, Kravtsov I, Vinogradov E, Creuzenet C, Liu H, et al 2014. Overlapping and distinct roles of Aspergillus fumigatus UDP-glucose 4-epimerases in galactose metabolism and the synthesis of galactose-containing cell wall polysaccharides. J Biol Chem. 289:1243-1256.
55. Leslie M. 2010. Cell biology. Beyond clotting: The powers of platelets. Science. 328:562-564.
56. Lever R, Page CP 2002. Novel drug development opportunities for heparin. Nat Rev Drug Discov. 1:140-148.
57. Linden MD, Jackson DE 2010. Platelets: Pleiotropic roles in atherogenesis and atherothrombosis. Int J Biochem Cell Biol. 42:1762-1766.
58. Liu FT, Rabinovich GA 2005. Galectins as modulators of tumour progression. Nat. Rev. Cancer. 5:29-41.
59. Liu FT, Rabinovich GA 2010. Galectins: Regulators of acute and chronic inflammation. Ann N YAcad Sci. 1183:158-182.
60. Lotan R, Belloni PN, Tressler RJ, Lotan D, Xu XC, Nicolson GL 1994. Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconj J. 11:462-468.
61. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 247:77-79.
62. McEver RP. 2001. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 86:746-756.
63. Merten M, Thiagarajan P. 2001. Role for sulfatides in platelet aggregation. Circulation. 104:2955-2960.
64. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW 2003. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg. 38:1075-1089.
65. Norling LV, Perretti M, Cooper D. 2009. Endogenous galectins and the control of the host inflammatory response. J Endocrinol. 201:169-184.
66. Osada M, Inoue O, Ding G, Shirai T, Ichise H, Hirayama K, Takano K, Yatomi Y, Hirashima M, Fujii H, et al. 2012. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem. 287:22241-22252.
67. Pacienza N, Pozner RG, Bianco GA, D'Atri LP, Croci DO, Negrotto S, Malaver E, Gomez RM, Rabinovich GA, Schattner M. 2008. The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J. 22:1113-1123.
68. Perollet C, Han ZC, Savona C, Caen JP, Bikfalvi A. 1998. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood. 91:3289-3299.
69. Petitou M, Herault JP, Bernat A, Driguez PA, Duchaussoy P, Lormeau JC, Herbert JM 1999. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature. 398:417-422.
70. Qi CL, Wei B, Ye J, Yang Y, Li B, Zhang QQ, Li JC, He XD, Lan T, Wang LJ 2014. P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells. PLoS ONE. 9:e91320.
71. Rabinovich GA, Croci DO 2012. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity. 36:322-335.
72. Rein CM, Desai UR, Church FC 2011. Serpin-glycosaminoglycan interactions. Methods Enzymol. 501:105-137.
73. Roberts DD. 1996. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 10:1183-1191.
74. Romaniuk MA, Croci DO, Lapponi MJ, Tribulatti MV, Negrotto S, Poirier F, Campetella O, Rabinovich GA, Schattner M. 2012. Binding of galectin-1 to alphaIIbbeta(3) integrin triggers "outside-in" signals, stimulates platelet activation, and controls primary hemostasis. FASEB J. 26:2788-2798.
75. Romaniuk MA, Tribulatti MV, Cattaneo V, Lapponi MJ, Molinas FC, Campetella O, Schattner M. 2010. Human platelets express and are activated by galectin-8. Biochem J. 432:535-547.
76. Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA 1999. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med. 190:803-814.
77. Rondina MT, Weyrich AS, Zimmerman GA 2013. Platelets as cellular effectors of inflammation in vascular diseases. CircRes. 112:1506-1519.
78. Rosenblum WI, Nelson GH, Wormley B, Werner P, Wang J, Shih CC 1996. Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke. 27:709-711.
79. Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, Bravo A, Mordoh J, Fainboim L, Podhajcer OL, Rabinovich GA 2004. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege. Cancer Cell. 5:241-251.
80. Sachais BS, Turrentine T, Dawicki McKenna JM, Rux AH, Rader D, Kowalska MA 2007. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/-mice. Thromb Haemost. 98:1108-1113.
81. Saint-Lu N, Oortwijn BD, Pegon JN, Odouard S, Christophe OD, de Groot PG, Denis CV, Lenting PJ 2012. Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor. Arterioscler Thromb Vasc Biol. 32:894-901.
82. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U. 2002. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer. 2: 521-528.
83. Scheuerer B, Ernst M, Durrbaum-Landmann I, Fleischer J, Grage-Griebenow E, Brandt E, Flad HD, Petersen F. 2000. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood. 95:1158-1166.
84. Schmid E, Muller TH, Budzinski RM, Binder K, Pfizenmaier K. 1995. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J Interferon Cytokine Res. 15:819-825.
85. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL, et al 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol. 156:235-246.
86. Semple JW, Italiano JE, Jr, Freedman J. 2011. Platelets and the immune continuum. Nat Rev Immunol. 11:264-274.
87. Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, Xia L, Varki A, McEver RP 2011. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood. 118:4015-4023.
88. Tan L, Kowalska MA, Romo GM, Lopez JA, Darzynkiewicz Z, Niewiarowski S. 1999. Identification and characterization of endothelial glycoprotein Ib using viper venom proteins modulating cell adhesion. Blood. 93:2605-2616.
89. Taylor KR, Gallo RL 2006. Glycosaminoglycans and their proteoglycans: Host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20:9-22.
90. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, et al 2010. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res. 70:6216-6224.
91. Thijssen VL, Griffioen AW 2014. Galectin-1 and galectin-9 in angiogenesis: A sweet couple. Glycobiology. 24:915-920.
92. Thijssen VL, Hulsmans S, Griffioen AW 2008. The galectin profile of the endothelium: Altered expression and localization in activated and tumor endothelial cells. Am J Pathol. 172:545-553.
93. Thijssen VL, Rabinovich GA, Griffioen AW 2013. Vascular galectins: Regulators of tumor progression and targets for cancer therapy. Cytokine Growth Factor Rev. 24:547-558.
94. Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, Fuertbauer E, Moser M, Haiko P, Fassler R, et al. 2010. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 115:3997-4005.
95. Vandendries ER, Furie BC, Furie B. 2004. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost. 92:459-466.
96. van Gils JM, Zwaginga JJ, Hordijk PL 2009. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol. 85:195-204.
97. Varki A, Etzler ME, Cummings RD, Esko JD 2009. Discovery and classification of glycan-binding proteins. In: Varki A, Cummings RD, Esko JD, Freeze H, Stanley P, Bertozzi CR, Hart G, Marth J, Etzler ME, editors. Essential of Glycobiology. 2nd ed. New York, Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press.
98. Wagner DD, Frenette PS 2008. The vessel wall and its interactions. Blood. 111:5271-5281.
99. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. 2003. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest. 112:853-862.
100. Wandall HH, Rumjantseva V, Sorensen AL, Patel-Hett S, Josefsson EC, Bennett EP, Italiano JE, Jr, Clausen H, Hartwig JH, Hoffmeister KM. 2012. The origin and function of platelet glycosyltransferases. Blood. 120:626-635.
101. Woodfin A, Voisin MB, Nourshargh S. 2007. PECAM-1: A multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol. 27:2514-2523.